Mark Van Oene sells PACB shares (NASDAQ: PACB) in February 2026
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Mark Van Oene reported sales of Common stock. The filing lists two transactions: 02/17/2026 sale of 129,790 shares for $204,549.04 and 02/18/2026 sale of 55,107 shares for $89,769.30. The filing also lists Restricted Stock to be sold on 03/02/2026.
Positive
- None.
Negative
- None.
Insights
Reported insider sales by Mark Van Oene on consecutive dates.
The filing itemizes two open-market sales: $204,549.04 for 129,790 shares on 02/17/2026 and $89,769.30 for 55,107 shares on 02/18/2026. These amounts are stated verbatim in the excerpt.
Timing and motivation are not disclosed in the excerpt; subsequent filings may provide context. Cash‑flow recipients are the selling holder as shown; the excerpt also lists restricted stock planned for sale on 03/02/2026.
FAQ
What sales did Mark Van Oene report for PACB?
Mark Van Oene reported two sales: 129,790 shares on 02/17/2026 for $204,549.04 and 55,107 shares on 02/18/2026 for $89,769.30. The filing lists these transactions verbatim.
Does the filing show any planned sales for PACB restricted stock?
Yes. The excerpt lists Restricted Stock to be sold on 03/02/2026 by the issuer. The entry appears under "Securities To Be Sold" with the listed date in the excerpt.
Who is the broker or intermediary shown in the Form 144?
The filing names Morgan Stanley Smith Barney LLC, Executive Financial Services with an address at 1 New York Plaza. That broker is listed in the filer information section of the excerpt.
Are the sale proceeds and dates provided in the PACB excerpt?
Yes. The excerpt provides transaction dates and proceeds: $204,549.04 for the 02/17/2026 sale and $89,769.30 for the 02/18/2026 sale. Figures are shown verbatim in the text.